|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.330 SEK | -5.34% |
|
-3.03% | -38.30% |
| 07/07 | Vivesto chairman Peter Zonabend increases his shareholding | FW |
| 01/07 | Vivesto Completes Enrollment in Cat Study of Paccal Vet | FW |
| Market Cap | 92.22M 9.56M 8.36M 7.72M 7.11M 13.41M 921M 13.7M 36.24M 451M 35.91M 35.12M 1.57B | P/E 2026 * |
-2.72x | P/E 2027 * | -1.99x |
|---|---|---|---|---|---|
| Enterprise Value | 84.22M 8.73M 7.63M 7.05M 6.49M 12.25M 841M 12.51M 33.09M 412M 32.79M 32.07M 1.43B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
56.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vivesto AB
| 1 day | -5.34% | ||
| 1 week | -3.03% | ||
| Current month | -2.00% | ||
| 1 month | -6.40% | ||
| 3 months | +3.35% | ||
| 6 months | -21.42% | ||
| Current year | -38.30% |
| 1 week | 8.25 |  | 8.9 |
| 1 month | 8 | | 9.18 |
| Current year | 7 | | 19.5 |
| 1 year | 7 | | 31.9 |
| 3 years | 7 | | 90.6 |
| 5 years | 7 | | 319 |
| 10 years | 7 | | 1,670 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Kinnman
CEO | Chief Executive Officer | 68 | 23/01/2023 |
Björn Svanström
DFI | Director of Finance/CFO | 55 | 01/07/2026 |
| Chief Tech/Sci/R&D Officer | 39 | 01/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 46 | 25/05/2022 | |
Hege Hellstrom
BRD | Director/Board Member | 61 | 26/09/2019 |
Pål Ryfors
BRD | Director/Board Member | 43 | 25/05/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/3/22 | Buy | Chief Executive Officer | 12,200 | 0.0027% | ||
| 24/3/22 | Others | Chairman | 120,000 | 0.0268% | ||
| 20/12/21 | Free | Chief Executive Officer | 2,250,000 | 0.5018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.34% | -3.03% | -64.40% | -69.09% | 10.11M | |
| +0.85% | -3.11% | +49.29% | +162.34% | 1,043B | |
| +1.23% | -2.34% | +53.56% | +58.28% | 602B | |
| +0.04% | +1.83% | +33.53% | +87.11% | 449B | |
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | |
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | |
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | |
| -1.42% | +0.73% | +22.50% | +61.06% | 201B | |
| -1.48% | -0.42% | +22.24% | +73.96% | 169B | |
| -0.36% | +3.30% | +1.79% | -31.03% | 143B | |
| Average | -0.61% | -0.37% | +20.10% | +43.50% | 347.71B | |
| Weighted average by Cap. | -0.04% | -1.82% | +37.79% | +83.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -31M -3.21M -2.81M -2.59M -2.39M -4.51M -309M -4.6M -12.18M -152M -12.07M -11.8M -526M | -46M -4.77M -4.17M -3.85M -3.54M -6.69M -459M -6.83M -18.07M -225M -17.91M -17.52M -781M |
| Net Debt | -8M -829K -725K -669K -617K -1.16M -79.85M -1.19M -3.14M -39.11M -3.11M -3.05M -136M | -10M -1.04M -906K -837K -771K -1.45M -99.81M -1.49M -3.93M -48.89M -3.89M -3.81M -170M |
Employees
4
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/07/26 | SEK 8.330 | -5.34% | 7,339 |
| 16/07/26 | SEK 8.800 | +6.02% | 5,702 |
| 15/07/26 | SEK 8.300 | -4.82% | 3,537 |
| 14/07/26 | SEK 8.720 | +3.32% | 4,907 |
| 13/07/26 | SEK 8.440 | -0.12% | 13,974 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
